B-cell prolymphocytic leukemia other diagnostic studies: Difference between revisions
No edit summary |
No edit summary |
||
Line 22: | Line 22: | ||
[[Category:Leukemia]] | [[Category:Leukemia]] | ||
[[Category: Lymphocytic leukemia]] | |||
[[Category:Disease]] | |||
[[Category:Hematology]] | |||
[[Category:Types of cancer]] | |||
[[Category:Oncology]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] |
Latest revision as of 19:33, 8 April 2019
B-cell prolymphocytic leukemia |
Differentiating B-cell prolymphocytic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
B-cell prolymphocytic leukemia other diagnostic studies On the Web |
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia other diagnostic studies |
FDA on B-cell prolymphocytic leukemia other diagnostic studies |
CDC on B-cell prolymphocytic leukemia other diagnostic studies |
B-cell prolymphocytic leukemia other diagnostic studies in the news |
Blogs on B-cell prolymphocytic leukemia other diagnostic studies |
Directions to Hospitals Treating B-cell prolymphocytic leukemia |
Risk calculators and risk factors for B-cell prolymphocytic leukemia other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Carlos A Lopez, M.D. [2]
Overview
Another diagnostic study for B-cell prolymphocytic leukemia includes immunophenotyping.
Immunophenotyping
Flow cytometric immunophenotyping indicates that the most common malignant cells are positive for:[1]